Helsinn Therapeutics

AKYNZEO - Cost

Last Updated: April 1st, 2024

HCPCS:

J1454

HCPCS Code Descriptor:

Injection, fosnetupitant 235 mg and palonosetron 0.25 mg

Medicare Payment Limit:

The AKYNZEO Medicare Payment Limit is $708.345

Average Sale Price:

AKYNZEO ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The AKYNZEO Medicare Co-insurance percentage is 19.733%. AKYNZEO's Medicare Co-insurance amount is $139.78 per HCPCS unit.

APC Code:

The Akynzeo APC Code is: 9099

APC Payment Limit:

The APC Payment Limit for AKYNZEO is available. Login to view.

Akynzeo Cost Information:

AKYNZEO, a product of Helsinn Therapeutics, became effective on January 1, 2019 and is associated with HCPCS J8655. Pricing has increased overall from its introduction. WAC and AWP rose by an estimated 20% between 2019 and 2024, while ASP increased by nearly 45%.

ACCESS PRICING AND MORE BY REGISTERING

Akynzeo’s wholesale acquisition cost (WAC) information was last updated on:
September 8, 2023
Akynzeo’s average wholesale price (AWP) information was last updated on:
September 8, 2023